Sign in
4

Changes in Ownership

Tarsus Pharmaceuticals, Inc. Filed Acc 0001519692-22-000010

Chief Financial Officer sold 5,000 shares at $16.54 ($82,700)

From the SEC's structured data for this filing

Trades in this filing

Greenstein Leonard M. · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-11-17 Sale : show line 1 in the form −5,000 $16.54 $82,700 49,289 D
Open-market sales · 5,000 sh · avg $16.54 · $82,700
Loading xslF345X03/wf-form4_166880594253223.xml…